Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
収録刊行物
-
- The Lancet
-
The Lancet 397 (10292), 2361-2371, 2021-06
Elsevier BV